S

SynAct Pharma AB
STO:SYNACT

Watchlist Manager
SynAct Pharma AB
STO:SYNACT
Watchlist
Price: 23.8 SEK 7.94%
Market Cap: 1.3B SEK

Wall Street
Price Targets

SYNACT Price Targets Summary
SynAct Pharma AB

Wall Street analysts forecast SYNACT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SYNACT is 26.52 SEK with a low forecast of 26.26 SEK and a high forecast of 27.3 SEK.

Lowest
Price Target
26.26 SEK
10% Upside
Average
Price Target
26.52 SEK
11% Upside
Highest
Price Target
27.3 SEK
15% Upside
SynAct Pharma AB Competitors:
Price Targets
SNDX
Syndax Pharmaceuticals Inc
86% Upside
688177
Bio-Thera Solutions Ltd
54% Upside
VLA
Valneva SE
86% Upside
PYXS
Pyxis Oncology Inc
509% Upside
CCCC
C4 Therapeutics Inc
446% Upside
CRNX
Crinetics Pharmaceuticals Inc
68% Upside
SPRB
Spruce Biosciences Inc
154% Upside
ALXO
ALX Oncology Holdings Inc
125% Upside

Revenue
Forecast

Revenue Estimate
SynAct Pharma AB

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
SynAct Pharma AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
SynAct Pharma AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SYNACT's stock price target?
Price Target
26.52 SEK

According to Wall Street analysts, the average 1-year price target for SYNACT is 26.52 SEK with a low forecast of 26.26 SEK and a high forecast of 27.3 SEK.

Back to Top